5 Cheap Small-Cap Stocks to Buy Before the Next Breakout
In this piece, we will take a look at five cheap small cap stocks to buy before the next breakout.
Avidity Biosciences Inc. (RNA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | VenBio Select Advisor Kurt Von Emster | 5,825,000 | $148,654,000 | +133% | 1.73% |
| 2. | RA Capital Management Peter Kolchinsky | 3,282,180 | $83,761,234 | +34% | 1.07% |
| 3. | Adage Capital Management Phill Gross And Robert Atchinson | 2,400,045 | $61,249,148 | +51% | 0.11% |
| 4. | Casdin Capital Eli Casdin | 2,084,841 | $53,205,142 | +78% | 3.95% |
| 5. | OrbiMed Advisors Samuel Isaly | 994,100 | $25,369,432 | 0.46% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.00 | 800,000 | Large Shareholder | 4,795,000 | 2021-08-04 | Filing | |
| $18.00 | 300,000 | Other | 2,514,545 | 2020-06-16 | Filing | |
| $18.00 | 950,000 | Large Shareholder | 3,995,000 | 2020-06-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $28.28 | 75,000 | 44,093 | 2024-05-14 | Filing | ||
| $25.54 | 28,000 | Officer, Director | 112,117 | 2024-05-07 | Filing | |
| $22.82 | 5,000 | Director | 14,830 | 2024-04-19 | Filing | |
| $27.11 | 20,000 | Director | 253,872 | 2024-04-03 | Filing | |
| $26.25 | 28,000 | Officer, Director | 112,117 | 2024-04-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 10,404,096 | $94,157,070 | 0% | |
| 2. | 6,689,789 | $60,542,590 | 0.94% | |
| 3. | 6,496,593 | $58,794,168 | 0% | |
| 4. | 5,629,103 | $50,943,382 | 3.34% | |
| 5. | 4,043,179 | $36,590,770 | 0% |
News See All
Is RNA A Good Stock To Buy According To Hedge Funds?
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity positions as of September...
BioMarin Pharmaceutical Inc. (BMRN) and Other Top New Picks of Healthcare-Focused Visium Asset Management
Jacob Gottlieb's Visium Asset Management has recently revealed its equity positions as of the end of the fourth quarter in a 13F filing with the Securities and Exchange Commission.
James Flynn, Deerfield Buy RNA-Themed Prosensa
James Flynn, Deerfield: Prosensa Holding NV (NASDAQ:RNA) recently became an addition in the equity portfolio of Deerfield Management, managed by James E. Flynn.
Billionaire Hedge Funds
